Cleared Special

K101885 - MEDTRONIC C315 DELIVERY CATHETER

K101885 is the FDA 510(k) clearance for MEDTRONIC C315 DELIVERY CATHETER by Medtronic, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Special 510(k) pathway after a 65-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2010
Decision
65d
Days
Class 2
Risk

K101885 is an FDA 510(k) clearance for the MEDTRONIC C315 DELIVERY CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Medtronic, Inc. (Mounds View, US). The FDA issued a Cleared decision on September 9, 2010 after a review of 65 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Medtronic, Inc. devices

Submission Details

510(k) Number K101885 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 06, 2010
Decision Date September 09, 2010
Days to Decision 65 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
60d faster than avg
Panel avg: 125d · This submission: 65d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 540
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K101885.
MEDTRONIC VASCULAR - HUB MATERIAL MODIFICATION TO THE 5F AND 8F LAUNCHER(R) GUIDE CATHETERS
K103386 · Medtronic, Inc. · Feb 2011
SUPERCROSS MICROCATHETER (130 CM), SUPERCROSS MICROCATHETER (150 CM) MODEL 5300, 5301
K101659 · Vascular Solutions, Inc. · Dec 2010
CONCENTRIC BALLOON GUIDE CATHETER
K102657 · Concentric Medical, Inc. · Nov 2010
HEADWAY 17 ADVANCED MICROCATHETER
K101542 · MicroVention, Inc. · Aug 2010
OCCLUSION BALLOON CATHETER MODEL OBC
K101877 · Cook, Inc. · Aug 2010
SCOUTPRO ACS
K101776 · Biotronik, Inc. · Jul 2010